Skip to main content

Animations

We are charting the path to a future free from Parkinson’s. Your support will get us there.

Illustrated close up of DNA.

Research Tools Catalog

To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.

Helpful Resources

  • Illustrated adjacent hexagons.

    Sponsored Tools Program

    Learn more about how MJFF can help share your tools.

  • Illustrated Parkinson's Disease Research Tools Consortium logo.

    Tools Consortium

    MJFF is working with industry to develop priority tools.

  • Illustrated brain on a presentation display.

    Preclinical Models

    Learn more about the various in vivo models used in Parkinson’s disease research.

Find a Research Tool

Filter by Tool Type or Gene/Protein Type to Organize Results

* = MJFF does not control pricing or terms of availability for this tool. 

Filters
Sort by
Order
Filters
Sort by
Order
Sort by
Order
Results (84)
Sort by:
CLN3 Knockout HCT-116 Cell Line
Immortalized Cell

HCT-116 cell line with homozygous knockout of CLN3. 

This cell line development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

Anticipated Availability: Q4 2026

  • CLN3
TMEM115 Antibody
Antibody

Rabbit monoclonal antibody directed against humanTMEM115 for immunoprecipitation of endogenous Golgi (tagless Golgi-IP).

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

  • TMEM115
VPS13C Antibody
Antibody

Rabbit monoclonal antibody directed against human/mouse/rat VPS13C. Suitable for use in immunoblotting applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

  • VPS13C
ATP13A2 Antibody (Hu - WB, ICC, IP)
Antibody

Rabbit monoclonal antibody directed against human ATP13A2 for immunoblotting, immunostaining, and immunoprecipitation applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative


 

  • ATP13A2
SLC18B1 Knockout HCT-116 Cell Line
Immortalized Cell

HCT-116 cell line with homozygous knockout of SLC18B1. 

This cell line development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

Anticipated Availability: Q4 2026

  • SLC18B1
Progranulin Antibody
Antibody

Rabbit monoclonal antibody directed against human progranulin. Suitable for use in immunoblotting, immunocytochemistry, immunohistochemistry, and immunoprecipitation applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

  • GRN
GALC Antibody
Antibody

Rabbit monoclonal antibody directed against human GALC. Developed for use in immunocytochemistry and immunoprecipitation applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

Anticipated Availability: Q4 2027

  • GALC
ITPKB Antibody
Antibody

Rabbit monoclonal antibody directed against human ITPKB. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

Anticipated Availability: Q4 2027

  • ITPKB
CLN3 Antibody
Antibody

Rabbit monoclonal antibody directed against human CLN3. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

Anticipated Availability: Q4 2027

  • CLN3
SPTSSB Antibody
Antibody

Rabbit monoclonal antibody directed against human SPTSSB. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. 

This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative

Anticipated Availability: Q4 2027

  • SPTSSB
Have questions or need additional information?

Email [email protected] with questions and to suggest new tools for us to develop. Or visit our FAQ page. 

"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD Mayo Clinic
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.